Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure

Nephrology Dialysis Transplantation

Volumn 12, Issue 4, 1997, Pages 724-728

  Tucker, B ^a   Fabbian, F ^b   Giles, M ^a   Thuraisingham, R C ^b   Raine, A E G ^a   Baker, L R I ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Ambulatory blood pressure (BP); Anaemia; Chronic renal failure (CRF); Hypertension; Left ventricular hypertrophy (LVH)

Indexed keywords

ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; CALCIUM; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMBULATORY MONITORING; ANEMIA; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 0030894230     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.4.724     Document Type: Article

References (24)

1. Raine AEG, Magreiter R, Brunner FP et al. Report on management, of renal failure in Europe, XXII, 1991. Nephrol Dial Transpantl 1992; 7 [Suppl 2]: 7-35
2. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis. An NIH Consensus Conference Statement. Ann Intern Med 1994; 121: 62-70
3. Kjellstrand CM, Hylander B, Collins AC. Mortality on dialysis. On the influence of early start, patients' characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990; 15: 483-490
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiography determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-1566
5. Pickering TG. Ambulatory monitoring and blood pressure variability. London, Science Press, 1991; Ch 13; 1-15
6. Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodelling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 1994; 12 [Suppl 10]: 117-127
7. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end stage renal disease. Kidney Int 1989; 36: 286-290
8. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end stage renal disease therapy. Kidney Int 1995; 47:186-192
9. Greaves SC, Gamble GD, Collins JF, Whalley GA, Sharpe DN. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 1994; 24: 768-776
10. Timio M, Lippi G, Venanzi S, Verdura C, Monarca C. Clinical aspects of left ventricular hypertrophy in uremia.In: Timio M, Wizemann V, Venanzi S, eds. Cardionephrology 3. Consenza, Editoriale Bios, 1995; 331-336
11. Ma KW, Green EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505-513
12. Silberberg JS, Rahal DP, Patton R, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end stage renal disease. Am J Cardiol 1989; 64: 222-224
13. Macdougall IC, Lewis MP, Saunders MJ et al. Long term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet 1990; 335: 489-493
14. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4:1486-1490
15. Baumgart P, Walger P, Gemen S, von Eiff M, Raidt H, Rahn KH. Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron 1991; 57: 293-298
16. Lipkin GW, Tucker B, Giles M, Raine AEG. Ambulatory blood pressure and left ventricular mass in cyclosporin-and non-cyclosporin-treated renal transplant recipients. J Hypertens 1993; 11: 439-442
17. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens 1991; 9 [Suppl 8]: S42-S44
18. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
19. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458
20. Levi D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham study. Am J Cardiol 1987; 59: 956-960
21. London GN, Fabiani F, Marchais SJ et al. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973-980
22. Verdecchia P, Porcellati C, Schillaci G et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801
23. Mancia G. Ambulatory blood pressure monitoring: research and clinical applications. J Hypertens 1990, 8 [Suppl 7]: S1-S13
24. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 226: 231-236